Comparative genomic hybridization in cartilaginous tumors

Toshihumi Ozaki, Daniel Wai, Karl Ludwig Schäfer, Norbert Lindner, Werner Böcker, Winfried Winkelmann, Barbara Dockhorn-Dworniczak, Christopher Poremba

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Genetic aberrations in cartilaginous tumors have not yet been well characterized. We analyzed the molecular-chromosomal aberrations in 10 chondrosarcomas (four Grade-3 tumors, four Grade-2 tumors and two Grade-1 tumors) and in three benign cartilaginous tumors (two enchondromas and one chondromyxoid fibroma). Genomic imbalances were detected in 9 out of 10 cases of chondrosarcomas. The median number of changes was 7.0 per tumor (range 0-23) and the gain-to-loss ratio was 1:1.4. The most frequent gains involved 7q, 5p, or 21q and the most frequent losses were 17p, 13q, 16p, or 22q. The three benign cartilaginous tumors each had two (0 gains and two losses), six (one gain and five losses) and eight (one gain and seven losses) chromosomal aberrations. Both of the gains occurred on 13q21 and losses were frequently observed on chromosomes 19 and 22q in all three cases. Loss of chromosomes 16p, 17p, 22q, or 19 loss were common in both chondrosarcomas and benign cartilaginous tumors. However, aberrations from chromosomes 2 to 11, 14, 15, 18, or 21 were detected only in chondrosarcomas. Therefore, although the number of aberrations between benign and malignant cartilaginous tumors appears to be similar, these two entities may be differentiated by determining which chromosomes are affected.

Original languageEnglish
Pages (from-to)1721-1725
Number of pages5
JournalAnticancer Research
Volume24
Issue number3 A
Publication statusPublished - May 2004

Fingerprint

Comparative Genomic Hybridization
Chondrosarcoma
Neoplasms
Chromosome Aberrations
Chromosomes
Chondroma
Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 2
Fibroma

Keywords

  • Cartilaginous tumors
  • Chondrosarcomas
  • Genomic hybridization

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ozaki, T., Wai, D., Schäfer, K. L., Lindner, N., Böcker, W., Winkelmann, W., ... Poremba, C. (2004). Comparative genomic hybridization in cartilaginous tumors. Anticancer Research, 24(3 A), 1721-1725.

Comparative genomic hybridization in cartilaginous tumors. / Ozaki, Toshihumi; Wai, Daniel; Schäfer, Karl Ludwig; Lindner, Norbert; Böcker, Werner; Winkelmann, Winfried; Dockhorn-Dworniczak, Barbara; Poremba, Christopher.

In: Anticancer Research, Vol. 24, No. 3 A, 05.2004, p. 1721-1725.

Research output: Contribution to journalArticle

Ozaki, T, Wai, D, Schäfer, KL, Lindner, N, Böcker, W, Winkelmann, W, Dockhorn-Dworniczak, B & Poremba, C 2004, 'Comparative genomic hybridization in cartilaginous tumors', Anticancer Research, vol. 24, no. 3 A, pp. 1721-1725.
Ozaki T, Wai D, Schäfer KL, Lindner N, Böcker W, Winkelmann W et al. Comparative genomic hybridization in cartilaginous tumors. Anticancer Research. 2004 May;24(3 A):1721-1725.
Ozaki, Toshihumi ; Wai, Daniel ; Schäfer, Karl Ludwig ; Lindner, Norbert ; Böcker, Werner ; Winkelmann, Winfried ; Dockhorn-Dworniczak, Barbara ; Poremba, Christopher. / Comparative genomic hybridization in cartilaginous tumors. In: Anticancer Research. 2004 ; Vol. 24, No. 3 A. pp. 1721-1725.
@article{ffba83650ce74d6cb1112b6975cd7eb9,
title = "Comparative genomic hybridization in cartilaginous tumors",
abstract = "Genetic aberrations in cartilaginous tumors have not yet been well characterized. We analyzed the molecular-chromosomal aberrations in 10 chondrosarcomas (four Grade-3 tumors, four Grade-2 tumors and two Grade-1 tumors) and in three benign cartilaginous tumors (two enchondromas and one chondromyxoid fibroma). Genomic imbalances were detected in 9 out of 10 cases of chondrosarcomas. The median number of changes was 7.0 per tumor (range 0-23) and the gain-to-loss ratio was 1:1.4. The most frequent gains involved 7q, 5p, or 21q and the most frequent losses were 17p, 13q, 16p, or 22q. The three benign cartilaginous tumors each had two (0 gains and two losses), six (one gain and five losses) and eight (one gain and seven losses) chromosomal aberrations. Both of the gains occurred on 13q21 and losses were frequently observed on chromosomes 19 and 22q in all three cases. Loss of chromosomes 16p, 17p, 22q, or 19 loss were common in both chondrosarcomas and benign cartilaginous tumors. However, aberrations from chromosomes 2 to 11, 14, 15, 18, or 21 were detected only in chondrosarcomas. Therefore, although the number of aberrations between benign and malignant cartilaginous tumors appears to be similar, these two entities may be differentiated by determining which chromosomes are affected.",
keywords = "Cartilaginous tumors, Chondrosarcomas, Genomic hybridization",
author = "Toshihumi Ozaki and Daniel Wai and Sch{\"a}fer, {Karl Ludwig} and Norbert Lindner and Werner B{\"o}cker and Winfried Winkelmann and Barbara Dockhorn-Dworniczak and Christopher Poremba",
year = "2004",
month = "5",
language = "English",
volume = "24",
pages = "1721--1725",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 A",

}

TY - JOUR

T1 - Comparative genomic hybridization in cartilaginous tumors

AU - Ozaki, Toshihumi

AU - Wai, Daniel

AU - Schäfer, Karl Ludwig

AU - Lindner, Norbert

AU - Böcker, Werner

AU - Winkelmann, Winfried

AU - Dockhorn-Dworniczak, Barbara

AU - Poremba, Christopher

PY - 2004/5

Y1 - 2004/5

N2 - Genetic aberrations in cartilaginous tumors have not yet been well characterized. We analyzed the molecular-chromosomal aberrations in 10 chondrosarcomas (four Grade-3 tumors, four Grade-2 tumors and two Grade-1 tumors) and in three benign cartilaginous tumors (two enchondromas and one chondromyxoid fibroma). Genomic imbalances were detected in 9 out of 10 cases of chondrosarcomas. The median number of changes was 7.0 per tumor (range 0-23) and the gain-to-loss ratio was 1:1.4. The most frequent gains involved 7q, 5p, or 21q and the most frequent losses were 17p, 13q, 16p, or 22q. The three benign cartilaginous tumors each had two (0 gains and two losses), six (one gain and five losses) and eight (one gain and seven losses) chromosomal aberrations. Both of the gains occurred on 13q21 and losses were frequently observed on chromosomes 19 and 22q in all three cases. Loss of chromosomes 16p, 17p, 22q, or 19 loss were common in both chondrosarcomas and benign cartilaginous tumors. However, aberrations from chromosomes 2 to 11, 14, 15, 18, or 21 were detected only in chondrosarcomas. Therefore, although the number of aberrations between benign and malignant cartilaginous tumors appears to be similar, these two entities may be differentiated by determining which chromosomes are affected.

AB - Genetic aberrations in cartilaginous tumors have not yet been well characterized. We analyzed the molecular-chromosomal aberrations in 10 chondrosarcomas (four Grade-3 tumors, four Grade-2 tumors and two Grade-1 tumors) and in three benign cartilaginous tumors (two enchondromas and one chondromyxoid fibroma). Genomic imbalances were detected in 9 out of 10 cases of chondrosarcomas. The median number of changes was 7.0 per tumor (range 0-23) and the gain-to-loss ratio was 1:1.4. The most frequent gains involved 7q, 5p, or 21q and the most frequent losses were 17p, 13q, 16p, or 22q. The three benign cartilaginous tumors each had two (0 gains and two losses), six (one gain and five losses) and eight (one gain and seven losses) chromosomal aberrations. Both of the gains occurred on 13q21 and losses were frequently observed on chromosomes 19 and 22q in all three cases. Loss of chromosomes 16p, 17p, 22q, or 19 loss were common in both chondrosarcomas and benign cartilaginous tumors. However, aberrations from chromosomes 2 to 11, 14, 15, 18, or 21 were detected only in chondrosarcomas. Therefore, although the number of aberrations between benign and malignant cartilaginous tumors appears to be similar, these two entities may be differentiated by determining which chromosomes are affected.

KW - Cartilaginous tumors

KW - Chondrosarcomas

KW - Genomic hybridization

UR - http://www.scopus.com/inward/record.url?scp=3242736668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242736668&partnerID=8YFLogxK

M3 - Article

C2 - 15274346

AN - SCOPUS:3242736668

VL - 24

SP - 1721

EP - 1725

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 A

ER -